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Sleep-promoting effects of threonine link
amino acid metabolism in Drosophila
neuron to GABAergic control of sleep
drive
Yoonhee Ki, Chunghun Lim*
School of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan,
Republic of Korea
Abstract Emerging evidence indicates the role of amino acid metabolism in sleep regulation.
Here we demonstrate sleep-promoting effects of dietary threonine (SPET) in Drosophila. Dietary
threonine markedly increased daily sleep amount and decreased the latency to sleep onset in a
dose-dependent manner. High levels of synaptic GABA or pharmacological activation of
metabotropic GABA receptors (GABAB-R) suppressed SPET. By contrast, synaptic blockade of
GABAergic neurons or transgenic depletion of GABAB-R in the ellipsoid body R2 neurons enhanced
sleep drive non-additively with SPET. Dietary threonine reduced GABA levels, weakened
metabotropic GABA responses in R2 neurons, and ameliorated memory deficits in plasticity
mutants. Moreover, genetic elevation of neuronal threonine levels was sufficient for facilitating
sleep onset. Taken together, these data define threonine as a physiologically relevant, sleep-
promoting molecule that may intimately link neuronal metabolism of amino acids to GABAergic
control of sleep drive via the neuronal substrate of sleep homeostasis.
Editorial note: This article has been through an editorial process in which the authors decide how
to respond to the issues raised during peer review. The Reviewing Editor’s assessment is that all
the issues have been addressed (see decision letter).
DOI: https://doi.org/10.7554/eLife.40593.001
Introduction
The circadian clock and sleep homeostasis are two key regulators that shape daily sleep behaviors in
animals (Borbe´ly, 1982). In stark contrast to the homeostatic nature of sleep, the internal machinery
of sleep is vulnerable to external (e.g., environmental change) or internal conditions (e.g., genetic
mutation) that lead to adaptive changes in sleep behaviors. Sleep behavior is conserved among
mammals, insects, and even lower eukaryotes (Allada and Siegel, 2008; Joiner, 2016). Since the
identification of the voltage-gated potassium channel Shaker as a sleep-regulatory gene in Drosoph-
ila (Cirelli et al., 2005), fruit flies have been one of the most advantageous genetic models to dissect
molecular and neural components that are important for sleep homeostasis and plasticity.
To date, a number of sleep-regulatory genes and neurotransmitters have been identified in ani-
mal models as well as in humans (Allada et al., 2017; Artiushin and Sehgal, 2017; Tomita et al.,
2017). For instance, the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) is known to
have a sleep-promoting role that is conserved in invertebrates and vertebrates. Hypomorphic muta-
tions in mitochondrial GABA-transaminase (GABA-T) elevate GABA levels and lengthen baseline
sleep in flies (Chen et al., 2015). The long sleep phenotype in GABA-T mutants accompanies higher
sleep consolidation and shorter latency to sleep onset, consistent with the observations that pharma-
cological enhancement of GABAergic transmission facilitates sleep in flies and mammals, including
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humans (Holmes and Sugden, 1975; Lancel et al., 1998; Schneider et al., 1977). In addition, resis-
tance to dieldrin (Rdl), a Drosophila homolog of the ionotropic GABA receptor, suppresses wake-
promoting circadian pacemaker neurons in adult flies to exert sleep-promoting effects
(Agosto et al., 2008; Chung et al., 2009; Liu et al., 2014a; Parisky et al., 2008). Similarly, 4,5,6,7-
tetrahydroisoxazolo[5,4 c]pyridin-3-ol (THIP), an agonist of the ionotropic GABA receptor, promotes
sleep in insects and mammals (Dissel et al., 2015; Faulhaber et al., 1997; Lancel, 1997).
Many sleep medications modulate GABAergic transmission. A prominent side effect of anti-epi-
leptic drugs relevant to GABA is causing drowsiness (Jain and Glauser, 2014). Conversely, glycine
supplements improve sleep quality in a way distinct from traditional hypnotic drugs, minimizing dele-
terious cognitive problems or addiction (Bannai and Kawai, 2012; Yamadera et al., 2007). In fact,
glycine or D-serine acts as a co-agonist of N-methyl-D-aspartate receptors (NMDARs) and promotes
sleep through the sub-type of ionotropic glutamate receptors (Dai et al., 2019; Kawai et al., 2015;
Tomita et al., 2015). Emerging evidence further supports the roles of amino acid transporters and
metabolic enzymes in sleep regulation (Aboudhiaf et al., 2018; Sonn et al., 2018; Stahl et al.,
2018). In particular, we have demonstrated that starvation induces the expression of metabolic
enzymes for serine biosynthesis in Drosophila brains, and elevates free serine levels to suppress
sleep via cholinergic signaling (Sonn et al., 2018). These observations prompted us to hypothesize
that other amino acids may also display neuro-modulatory effects on sleep behaviors.
Results
Dietary threonine promotes sleep and facilitates sleep onset
To determine if amino acid supplements modulate sleep in Drosophila, we employed an infrared
beam-based Drosophila activity monitor (DAM) that detects locomotor activity in individual flies
(Pfeiffenberger et al., 2010). Sleep behaviors in wild-type flies fed 5% sucrose containing 17.5 mM
of each amino acid were quantitatively assessed in 12 hr light:12 hr dark (LD) cycles at 25˚C. The
strongest impact on sleep quantity and quality was observed with cysteine supplementation
(Figure 1A and Figure 1—figure supplement 1). However, dietary cysteine compromised locomo-
tion and caused high lethality during our sleep assay (see Figure 1—figure supplement 6). We thus
excluded it from further analyses. Intriguingly, threonine supplementation potently elevated total
sleep amount by increasing the number of sleep bouts (Figure 1A and Figure 1—figure supple-
ment 1). In addition, dietary threonine evidently shortened the latency to sleep onset after lights-off.
The sleep-promoting effects of dietary threonine (SPET) were dose-dependent and observed in both
male and female flies (Figure 1—figure supplement 2). Transgenic silencing of sensory neurons that
express either gustatory receptors (Gr66a, Gr33a, and Gr5a) or olfactory co-receptor (Lone et al.,
2016) negligibly affected SPET as compared to relevant heterozygous controls (Figure 1—figure
supplement 3). These results suggest that sensory perception of dietary threonine is less likely
responsible for SPET. We further found that flies fed nutrient-rich food containing additional protein
sources (e.g., cornmeal, yeast) also exhibited SPET, although higher concentrations of threonine
were required (Figure 1—figure supplement 4). We reason that flies may ingest smaller volume of
daily food on nutrient-rich diet than on sucrose-only diet as a compensation for their difference in
calories per volume (Carvalho et al., 2005). Nonetheless, these data indicate that SPET is not lim-
ited to carbohydrate-only diets.
It has previously been shown that flies exhibit a positional preference relative to their food source,
depending on sleep-wake cycles or genetic backgrounds (Donelson et al., 2012). These observa-
tions raised the possibility that threonine supplementation might have affected the positional prefer-
ence in wild-type flies, thereby leading to the overestimation of their sleep amount by the DAM-
based analyses (Figure 1—figure supplement 5A). To exclude this possibility, we placed individual
flies into circular arenas in which food is provided unilaterally from the whole floor (Figure 1—figure
supplement 5B and C). Locomotor activities of individual flies were then video-recorded in LD
cycles. The video-based assessment of sleep behaviors in control- versus threonine-fed flies further
confirmed SPET (Figure 1—figure supplement 5D). Lower waking activity (i.e., beam crosses per
minute during wakefulness) was observed in threonine-fed flies by the DAM analysis (Figure 1—fig-
ure supplement 1). Dietary threonine actually shortened total traveling distance, but it did not sig-
nificantly affect moving speed in the video analysis (Figure 1—figure supplement 5D and
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Figure 1. Dietary threonine promotes sleep and facilitates sleep onset. (A) Wild-type male flies were individually loaded on to 5% sucrose food
containing 17.5 mM of each amino acid (day 0) and entrained in LD cycles at 25˚C. Total sleep amount (top) and latency to sleep onset after lights-off
(bottom) were calculated in individual flies on day 4 and averaged for each amino acid. Essential and non-essential amino acids are grouped separately
as shown at the top. The width of a violin plot indicates the density of samples. The violins are restricted by the observed ranges. Error bars indicate
mean ±95% confidence interval (CI) (n = 29–213). *p<0.05, **p<0.01, ***p<0.001 to control (i.e., no amino acid supplement) as determined by one-way
ANOVA, Dunnett’s multiple comparisons test. (B) Control- and threonine-fed flies were awakened by a range of mechanical stimuli 4 hr after lights-off
on day 4. Aroused flies were defined if they displayed no activity for >5 min prior to the stimulus but showed any locomotor response within 10 min.
The percentage of aroused flies per condition was averaged from three independent experiments (top). Error bars indicate mean ± SEM (n = 3). Sleep
latency after arousal was calculated in individual flies and averaged for each condition (bottom). Error bars indicate mean ±95% CI (n = 12–27). Two-way
ANOVA detected significant effects of dietary threonine on sleep latency after arousal (F[1,119]=20.43, p<0.0001) but not on % aroused flies (F[1,16]
=0.227, p=0.6402). n.s., not significant; **p<0.01, ***p<0.001 as determined by Bonferroni’s multiple comparisons test.
DOI: https://doi.org/10.7554/eLife.40593.002
The following figure supplements are available for figure 1:
Figure supplement 1. Dietary threonine increases the number of sleep bouts but decreases waking activities.
DOI: https://doi.org/10.7554/eLife.40593.003
Figure supplement 2. Sleep-promoting effects of dietary threonine (SPET) are dose-dependent and observed in both male and female flies.
DOI: https://doi.org/10.7554/eLife.40593.004
Figure supplement 3. Transgenic silencing of sensory neurons that express either gustatory or olfactory receptors does not abolish SPET.
DOI: https://doi.org/10.7554/eLife.40593.005
Figure supplement 4. Wild-type flies fed protein-rich food display SPET comparably to those fed sucrose-based food.
DOI: https://doi.org/10.7554/eLife.40593.006
Figure supplement 5. A video-based sleep analysis validates SPET in threonine-fed flies.
DOI: https://doi.org/10.7554/eLife.40593.007
Figure supplement 6. Dietary threonine does not impair general locomotion.
DOI: https://doi.org/10.7554/eLife.40593.008
Figure supplement 7. Dietary threonine induces a higher sleep drive.
DOI: https://doi.org/10.7554/eLife.40593.009
Figure supplement 8. Genetic loss of Lk or Lkr function does not affect SPET.
DOI: https://doi.org/10.7554/eLife.40593.010
Ki and Lim. eLife 2019;8:e40593. DOI: https://doi.org/10.7554/eLife.40593 3 of 24
Research Communication Genetics and Genomics Neuroscience
Figure 1—figure supplement 6). Therefore, it is unlikely that threonine supplementation causes
general locomotor impairment responsible for low waking activity or long sleep phenotypes. It is
also noteworthy that low waking activity does not necessarily associate with long sleep phenotypes
as observed with tryptophan supplementation (Figure 1A and Figure 1—figure supplement 1).
To examine if SPET affects arousal threshold (i.e., sleep depth), we quantified arousal responses
to sensory stimuli during sleep. Control- and threonine-fed flies displayed no significant differences
in the percentage of flies aroused by a given range of mechanical stimuli in the middle of night
(Figure 1B). However, threonine-fed flies displayed shorter latency to the first post-stimulus bout of
sleep. Consistent results were obtained when nighttime sleep was interrupted by a pulse of light
(Figure 1—figure supplement 7). Taken together, these data suggest that a higher sleep drive, but
not a change in sleep depth, may contribute to SPET.
Circadian clock-dependent control of sleep onset is dispensable for
SPET
Rdl and wide awake (wake) are two evolutionarily conserved genes that contribute to circadian
clock-dependent control of sleep onset in Drosophila (Agosto et al., 2008; Liu et al., 2014a). A cir-
cadian transcription factor, CLOCK (CLK), drives daily rhythmic transcription of wake, particularly in a
subset of clock neurons that express the circadian neuropeptide PIGMENT-DISPERSING FACTOR
(PDF) (Liu et al., 2014a). Subsequently, WAKE acts as a clock output molecule that interacts with
RDL, silences the wake-promoting PDF neurons, and facilitates sleep onset. Therefore, we asked
whether circadian clocks and their regulation of sleep drive would be necessary for SPET.
We first confirmed that female mutants trans-heterozygous for hypomorphic Rdl alleles had
shorter sleep latency in control-fed condition than their heterozygous controls (Agosto et al., 2008)
(Figure 2—figure supplement 1). Dietary threonine, however, shortened sleep latency additively
with the loss of Rdl function (p=0.084, by two-way ANOVA). In addition, trans-heterozygous Rdl
mutation did not compromise SPET on daily sleep amount compared to either heterozygous con-
trols. We next examined if SPET was suppressed in arrhythmic clock mutants. Loss of Clk function
caused long sleep latency in fed condition (Liu et al., 2014a), and SPET had additive effects on the
latency phenotype in Clk mutants (Figure 2A, p=0.14 by two-way ANOVA). On the other hand,
short sleep latency in per mutants (Liu et al., 2014a) likely caused a floor effect, leading to no signif-
icant SPET on their sleep latency (Figure 2A). Nonetheless, wild-type and both clock mutants
showed comparable SPET on daily sleep amount (Figure 2A, p=0.8367 for Clk mutants; p=0.2573
for per mutants by two-way ANOVA). Finally, it has been shown that overexpression of dominant-
negative CLK proteins (CLKDN) in PDF neurons is sufficient to abolish free-running circadian locomo-
tor rhythms (Tanoue et al., 2004) and lengthen sleep latency (Liu et al., 2014a). We observed con-
sistent effects of CLKDN overexpression in PDF neurons on sleep drive in control-fed condition, but
it did not suppress SPET (Figure 2B). These lines of our genetic evidence suggest that SPET does
not require clock-dependent control of sleep onset by circadian clock genes or PDF neurons.
To further test the implication of circadian clocks in SPET, we compared SPET in different light-
dark conditions. Constant dark (DD) following LD entrainment eliminates masking behaviors in direct
response to the light transitions while allowing free-running circadian rhythms by endogenous clocks
(Allada and Chung, 2010). We found that DD did not suppress SPET but rather exaggerated it par-
ticularly in male flies (Figure 2C and D, p<0.0001 to SPET on sleep amount or sleep latency in LD by
two-way ANOVA). SPET was thus evident even in the absence of light. By contrast, constant light
(LL) abolishes circadian rhythms in wild-type flies (Emery et al., 2000). Consequently, control-fed
flies completely lost their daily rhythms in sleep-wake cycles (Figure 2C and D) and dampened their
sleep latency in LL (Figure 2—figure supplement 2). This caused a floor effect whereby SPET was
barely detectable, particularly on sleep latency at the transition of subjective day and night in LL as
compared to LD. Nonetheless, we observed significant effects of dietary threonine on sleep latency
(i.e., shorter sleep latency in threonine-fed flies) when SPET on sleep latency was compared among
different time-points in LL (p=0.0003 to control-fed male in LL; p<0.0001 to control-fed female in LL
by two-way ANOVA). Dietary threonine also increased daily sleep amount in LL (Figure 2C and D).
In fact, male flies displayed comparable SPET on daily sleep amount in LD and LL (p=0.1835 by two-
way ANOVA). Collectively, these data support that higher sleep drive by SPET likely operates in a
manner independent of circadian clocks and their control of sleep onset.
Ki and Lim. eLife 2019;8:e40593. DOI: https://doi.org/10.7554/eLife.40593 4 of 24
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Genetic or pharmacological elevation of synaptic GABA suppresses
SPET
To elucidate genetic and neural mechanisms underlying SPET, we examined effects of dietary threo-
nine on sleep behaviors in loss-of-function mutants of other sleep-regulatory genes. Interestingly,
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Figure 2. Circadian rhythms and clock-dependent control of sleep onset are dispensable for SPET. (A) Arrhythmic clock mutants were loaded on to 5%
sucrose food containing the indicated amount of threonine (day 0) and entrained in LD cycles at 25˚C. Sleep behaviors in individual female flies were
analyzed similarly to the data presented in Figure 1A. Two-way ANOVA detected no significant interaction of SPET with per01 (F[1,159]=1.293,
p=0.2573 for sleep amount) or ClkJrk (F[1,160]=0.0426, p=0.8367 for sleep amount; F[1,160]=2.199, p=0.14 for sleep latency). Error bars indicate
mean ±95% CI (n = 35–46). (B) PDF neuron-specific overexpression of dominant-negative CLK proteins (CLKDN) lengthened sleep latency in female flies
fed control food (5% sucrose) but it did not suppress SPET. Error bars indicate mean ±95% CI (n = 26–42). (C and D) Wild-type flies were loaded on to
5% sucrose food containing the indicated amount of threonine (day 0) and then entrained in LD or constant light (LL) cycles at 25˚C. For sleep analyses
in constant dark (DD), LD-entrained flies were transferred to DD at the end of day 4 and their sleep was monitored during the first DD cycle (day 5).
Averaged sleep profiles (% sleep per 30 min bin) on day 4 (LD or LL) or day 5 (DD) were shown at the top. Data represent mean ± SEM (n = 25–46).
Error bars in the violin plots indicate mean ±95% CI (n = 25–46). n.s., not significant; *p<0.05, **p<0.01, ***p<0.001 as determined by two-way ANOVA,
Tukey’s multiple comparisons test.
DOI: https://doi.org/10.7554/eLife.40593.011
The following figure supplements are available for figure 2:
Figure supplement 1. Genetic loss of Rdl function does not suppress SPET.
DOI: https://doi.org/10.7554/eLife.40593.012
Figure supplement 2. Constant light (LL) strongly dampens daily rhythms in sleep-wake cycles and sleep latency, but SPET is detectable in LL.
DOI: https://doi.org/10.7554/eLife.40593.013
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SPET was potently suppressed in GABA-T mutants trans-heterozygous for a null allele (GABA-TPL)
over chromosomal deficiency (Figure 3—figure supplement 1). Their sensitivity to SPET was par-
tially but significantly rescued by transgenic overexpression of wild-type GABA-T (Chen et al.,
2015). However, the trans-heterozygosity of these strong GABA-T alleles promoted sleep in control-
fed condition (Chen et al., 2015), raising the possibility that a ceiling effect may mask SPET. We
thus tested SPET in weaker allelic combinations of GABA-T mutations. GABA-T mutants trans-het-
erozygous for null over hypomorphic alleles (GABA-TF or GABA-TLL) (Chen et al., 2015) did not sig-
nificantly affect baseline sleep in control-fed condition as compared to their heterozygous controls
(Figure 3A). Nonetheless, these mutants still exhibited the resistance to SPET (p<0.0001 to SPET on
sleep amount or sleep latency in heterozygous controls by two-way ANOVA).
To independently confirm the implication of GABA-T function in SPET, we pharmacologically
silenced the enzymatic activity of GABA-T in wild-type flies by oral administration of ethanolamine
O-sulfate (EOS), a GABA-T inhibitor. EOS supplement did not significantly increase daily sleep
amount at a given dose in our sleep assay, but it modestly shortened sleep latency in wild-type flies
fed control food (Figure 3B). However, SPET was suppressed in EOS-fed flies (p<0.0001 to SPET on
sleep amount or sleep latency in control flies by two-way ANOVA) similarly as in GABA-T mutants.
Considering that GABA-T is a mitochondrial enzyme which metabolizes GABA into succinic semial-
dehyde (Chen et al., 2015), we hypothesized that high GABA levels at GABAergic synapses might
interfere with sleep drive by dietary threonine. This idea was further supported by our observation
that nipecotic acid (NipA), which blocks GABA reuptake from synaptic clefts (Leal and Neckameyer,
2002), comparably suppressed SPET (Figure 3B, p<0.0001 to SPET on sleep amount or sleep
latency in control flies by two-way ANOVA). Collectively, these genetic and pharmacological data
suggest that SPET may involve a sleep drive relevant to GABA. In addition, evidence from our adult-
specific manipulations of GABA levels excludes possible developmental effects of GABA-T mutation
or GABA on SPET.
Dietary threonine decreases GABA and glutamate levels
Genetic deficit in the metabolic conversion of GABA to glutamate leads to high levels of GABA in
GABA-T mutants while they have low levels of glutamate and alpha-ketoglutarate, a glutamate
derivative that enters tricarboxylic cycle (Maguire et al., 2015). These changes in GABA-derived
metabolites are accompanied with impairment in energy homeostasis as supported by the high ratio
of NAD+/NADH levels and low ATP levels in GABA-T mutants. Consequently, GABA-T mutants can-
not survive on carbohydrate-based food (i.e., 5% sucrose +1.5% agar) but their metabolic stress phe-
notypes are rescued by the supplement of glutamate and other amino acids that can be
metabolized to glutamate. We thus asked if dietary threonine would induce relevant metabolic
changes that may be responsible for SPET.
Dietary threonine did not significantly affect ATP levels or the ratio of NAD+/NADH levels (Fig-
ure 4—figure supplement 1A). However, pyruvate levels were selectively elevated in threonine-fed
flies (p<0.0001 to succinate by one-way ANOVA, Dunnett’s multiple comparisons test), possibly due
to the metabolism of dietary threonine into pyruvate via L-2-amino-acetoacetate (Figure 4—figure
supplement 2). Nonetheless, dietary pyruvate itself did not promote sleep (Figure 4—figure sup-
plement 1B). Quantification of free amino acids further revealed that dietary threonine reduced the
relative levels of proline, histidine, alanine, glutamate, and GABA among other amino acids
(Figure 4A, p<0.05 or p<0.001 to arginine by one-way ANOVA, Dunnett’s multiple comparisons
test). Since it has been shown that glutamate acts as either a wake- or sleep-promoting neurotrans-
mitter in Drosophila (Guo et al., 2016; Robinson et al., 2016; Tomita et al., 2015;
Zimmerman et al., 2017), we asked if co-administration of threonine and glutamate could suppress
SPET. Glutamate supplement, however, negligibly affected SPET (Figure 4—figure supplement 3,
p=0.91 for sleep amount; p=0.516 for sleep latency by two-way ANOVA), suggesting that dietary
threonine may not limit glutamate levels to promote sleep. It is noteworthy that glutamate supple-
ment can rescue metabolic stress, but not sleep phenotypes, in GABA-T mutants, indicating inde-
pendent regulatory pathways of GABA-relevant metabolism and sleep (Maguire et al., 2015).
Ki and Lim. eLife 2019;8:e40593. DOI: https://doi.org/10.7554/eLife.40593 6 of 24
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Figure 3. Genetic or pharmacological elevation of GABA suppresses SPET. (A) GABA-T trans-heterozygous mutants were resistant to SPET. Sleep
behaviors in individual male flies were analyzed similarly to the data presented in Figure 1A. Two-way ANOVA detected significant suppression of
SPET in GABA-T trans-heterozygous mutants on sleep amount (F[2,403]=39.21, p<0.0001 for GABA-TPL/GABA-TF; F[2,430]=32.28, p<0.0001 for GABA-
TPL/GABA-TLL; F[2,454]=13.99, p<0.0001 for GABA-TF/GABA-TLL) and sleep latency (F[2,403]=13.35, p<0.0001 for GABA-TPL/GABA-TF; F[2,430]=15.97,
p<0.0001 for GABA-TPL/GABA-TLL; F[2,454]=9.324, p=0.0001 for GABA-TF/GABA-TLL), compared to their heterozygous controls. Error bars indicate
mean ±95% CI (n = 32–114).(B) Co-administration of GABA-T inhibitor (EOS) or GABA transporter inhibitor (NipA) with threonine blocked SPET in wild-
type flies. Where indicated, EOS or NipA was added to the sucrose food containing the increasing amounts of threonine. Sleep behaviors were
analyzed as described above. Two-way ANOVA detected significant interaction of SPET with EOS (F[2,155]=14.07, p<0.0001 for sleep amount; F[2,155]
=11.2, p<0.0001 for sleep latency) or NipA (F[2,162]=13.09, p<0.0001 for sleep amount; F[2,162]=26.58, p<0.0001 for sleep latency). Error bars indicate
mean ±95% CI (n = 22–37) .n.s., not significant; *p<0.05, **p<0.01, ***p<0.001 as determined by Tukey’s multiple comparisons test.
DOI: https://doi.org/10.7554/eLife.40593.014
The following figure supplement is available for figure 3:
Figure supplement 1. Transgenic overexpression of wild-type GABA-T partially rescues baseline sleep and SPET in GABA-T mutants.
DOI: https://doi.org/10.7554/eLife.40593.015
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Figure 4. Down-regulation of metabotropic GABA transmission likely mediates SPET. (A) Dietary threonine decreased the relative levels of select amino
acids including GABA and glutamate. Wild-type male flies were loaded on to standard cornmeal-yeast-agar food containing either 0 mM (control) or 50
mM threonine, and then entrained in LD cycles at 25˚C for 4 days before harvest. Relative levels of free amino acids in head extracts from threonine-fed
flies were measured using ion exchange chromatography and then normalized to those in head extracts from control-fed flies. Error bars indicate
mean ± SEM (n = 3). n.s., not significant; *p<0.05, ***p<0.001 to the relative levels of arginine as determined by one-way ANOVA, Dunnett’s multiple
comparisons test. (B) Conditional blockade of GABAergic transmission promoted sleep in control-fed condition and masked SPET. Transgenic flies
expressing a temperature-sensitive allele of shibire (shibirets) were loaded on to 5% sucrose food containing the indicated amount of threonine (day 0)
and entrained in LD cycles at 29˚C (restrictive) or 21˚C (permissive). Sleep behaviors in individual male flies were analyzed on day 3 (29˚C) or day 6 (21˚C)
since low temperature delayed SPET even in heterozygous controls. Two-way ANOVA detected significant masking of SPET by shibirets overexpression
in GAD1-expressing cells at 29˚C (F[2,197]=14.06, p<0.0001 for sleep amount; F[2,196]=6.953, p=0.0012 for sleep latency), but not at 21˚C (F[2,184]
=2.055, p=0.131 for sleep amount; F[2,184]=0.1835, p=0.8325 for sleep latency) as compared to their heterozygous controls. Error bars indicate
mean ±95% CI (n = 14–63 for 29˚C; n = 25–35 for 21˚C). (C) Pan-neuronal deletion of metabotropic GABA receptors (GABAB-R1 and GABAB-R3) by
transgenic RNA interference (RNAi) increased daily sleep amount in control-fed condition and masked SPET. Locomotor activities in individual male
flies were monitored similarly to the data presented in Figure 1A. Sleep behaviors were analyzed on day 3 to better compare the sensitivity to SPET
among different genotypes. Two-way ANOVA detected significant masking of SPET by the pan-neuronal RNAi on sleep amount (F[2,236]=8.913,
p=0.0002 for GABAB-R1
RNAi#2; F[2,317]=16.78; F[2,193]=4.594, p=0.0112 for GABAB-R3
RNAi#1) and sleep latency (F[2,193]=3.267, p=0.0403 for GABAB-
R3RNAi#1) as compared to their heterozygous controls. Error bars indicate mean ±95% CI (n = 24–50). (D) Oral administration of SKF-97541 (an agonist of
metabotropic GABA receptor), but not of THIP (an agonist of ionotropic GABA receptor), suppressed SPET. Sleep behaviors in individual male flies
were analyzed as described above. Where indicated, THIP (5 mg/ml) or SKF-97541 (1 mg/ml) was added to the behavior food. Two-way ANOVA
Figure 4 continued on next page
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Down-regulation of GABA transmission via metabotropic GABA
receptors induces sleep and masks SPET
To determine if dietary threonine affects GABA transmission, we examined intracellular Ca2+ levels
in glutamate decarboxylase 1 (GAD1)-expressing GABAergic neurons as a quantitative proxy for
their neural activity. Since threonine supplementation exhibited cumulative effects on baseline sleep
in LD cycles, we reasoned that it might be necessary to monitor the long-term changes in neural
activity associated with threonine diet. Accordingly, we employed a transgenic reporter of the cal-
cium-sensitive transcriptional activator LexA (CaLexA) that translocates into nucleus in a calcium-
dependent manner and induces the expression of green fluorescent protein (GFP)
(Masuyama et al., 2012). Confocal microscopy of adult fly brains revealed the strongest GFP
expression by the GABAergic CaLexA in neurons projecting into antennal lobe (AL), medial antenno-
cerebral tract (mACT), and lateral horn (LH) among other GAD1-expressing neurons (Figure 4—fig-
ure supplement 4A). These observations suggest a heterogeneity in baseline Ca2+ levels among
GABAergic neuron subsets. Interestingly, threonine, but not arginine, induced the CaLexA signal in
a subset of GABAergic neurons adjacent to the antennal lobe (LN, lateral neurons) (Figure 4—figure
supplement 4B and C). By contrast, no detectable changes were observed in the CaLexA signals
from other sleep-regulatory loci such as mushroom body or dopaminergic neurons upon threonine
diet (Figure 4—figure supplement 4D and E). Although the sensitivity of CaLexA may limit the
detectable size and duration of Ca2+ changes in our experimental condition, these results support
the relative specificity of Ca2+ response in LN to the threonine diet. Given that dietary threonine
decreased GABA levels, GABAergic LN may selectively display a compensatory increase in their neu-
ral activity. Alternatively, it is possible that auto-inhibitory GABA receptors (Pinard et al., 2010) are
expressed more strongly in these LN than other GABAergic neurons. Low GABA levels in threonine-
fed flies may then relieve this negative feedback and stimulate their neural activity upon threonine
diet. In either case, these results prompted us to ask if GABAergic transmission would be necessary
for SPET.
To further validate the implication of GABAergic transmission in SPET, we expressed a shibirets
transgene (Kitamoto, 2001) in GAD1-expressing GABAergic neurons. The shibirets is a tempera-
ture-sensitive mutant allele in a Drosophila homolog of dynamin that interferes with synaptic vesicle
recycling and thus, blocks synaptic transmission at restrictive (29˚C) but not permissive (21˚C) tem-
perature. The conditional blockade of synaptic transmission in GABAergic neurons induced sleep in
control-fed condition (Figure 4B), and it significantly masked SPET (p<0.0001 for sleep amount;
p=0.0012 for sleep latency by two-way ANOVA). These long sleep phenotypes were partially but
consistently observed by the pan-neuronal depletion of metabotropic GABA receptor R1 or R3
(GABAB-R1 or GABAB-R3) (Figure 4C). However, their effects were in contrast with those observed
by hypomorphic GABA-T mutations that suppressed SPET but did not promote baseline sleep in
control-fed condition. We further found that co-administration of an agonist of metabotropic GABA
Figure 4 continued
detected significant effects of SKF-97541 on SPET (F[1,143]=17.39, p<0.0001 for sleep amount; F[1,143]=6.898, p=0.0096 for sleep latency).Error bars
indicate mean ±95% CI (n = 27–53). n.s., not significant; *p<0.05, **p<0.01, ***p<0.001 as determined by Tukey’s multiple comparisons.
DOI: https://doi.org/10.7554/eLife.40593.016
The following figure supplements are available for figure 4:
Figure supplement 1. Dietary threonine selectively elevates pyruvate levels but dietary pyruvate itself does not promote sleep.
DOI: https://doi.org/10.7554/eLife.40593.017
Figure supplement 2. A metabolic pathway of serine, glycine, and threonine.
DOI: https://doi.org/10.7554/eLife.40593.018
Figure supplement 3. Glutamate supplement does not suppress SPET.
DOI: https://doi.org/10.7554/eLife.40593.019
Figure supplement 4. Dietary threonine elevates intracellular Ca2+ levels in a subset of GABAergic neurons.
DOI: https://doi.org/10.7554/eLife.40593.020
Figure supplement 5. Pan-neuronal depletion of metabotropic GABA receptor R1, but not R2, affects SPET.
DOI: https://doi.org/10.7554/eLife.40593.021
Figure supplement 6. Structural and functional relevance of alpha-ketobutyric acid, a threonine derivative, to GABA and GABA derivatives.
DOI: https://doi.org/10.7554/eLife.40593.022
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receptors (SKF-97541), but not of ionotropic GABA receptors (THIP), with threonine suppressed
SPET particularly on sleep latency (Figure 4D, p=0.1285 for THIP; p=0.0096 for SKF-97541 by two-
way ANOVA). Adult-specific manipulations of GABAergic transmission by the temperature-sensitive
allele or by the oral administration of receptor-specific agonists excluded possible developmental
effects of GABA on SPET. Collectively, these data suggest a possible model that SPET involves the
down-regulation of metabotropic GABA transmission to induce sleep whereas genetic or pharmaco-
logical elevation of the GABA transmission interferes with this process to suppress SPET. Nonethe-
less, the multimeric nature of GABA receptors and their expression in either wake- or sleep-
promoting neurons likely complicate the net effects of general activation or silencing of GABA trans-
mission on sleep. We thus asked if more specific suppression of the metabotropic GABA transmis-
sion in a dedicated neural locus would induce sleep and mask SPET, thereby supporting our
hypothesis above.
Metabotropic GABA transmission in ellipsoid body R2 neurons
contributes to SPET
A previous study mapped a subset of ellipsoid body (EB) neurons in the adult fly brain (hereafter
referred to as R2 EB neurons) as a neural locus important for sleep homeostasis (Liu et al., 2016).
Neural activity in R2 EB neurons positively correlates to sleep need, and the transgenic excitation of
R2 EB neurons is sufficient to induce rebound sleep. Considering that SPET involves a higher sleep
drive, we hypothesized that dietary threonine might affect the activity of R2 EB neurons via metabo-
tropic GABA transmission. Since the intracellular signaling downstream of metabotropic GABA
receptors triggers cAMP synthesis (Onali et al., 2003), we employed Epac1-camps, a transgenic
fluorescence resonance energy transfer (FRET) sensor for cyclic adenosine monophosphate (cAMP)
(Shafer et al., 2008) (Figure 5A). Our live-brain imaging of the Epac1-camps in R2 EB neurons
detected a dose-dependent increase in cAMP levels by a bath application of GABA (Figure 5—fig-
ure supplement 1A). Pre-incubation with tetrodotoxin did not affect the GABA-induced elevation of
cAMP levels, indicating cell-autonomous effects of GABA on these R2 EB neurons (Figure 5—figure
supplement 1B). We further found that dietary threonine modestly, but significantly, dampened the
GABA response in R2 EB neurons (Figure 5B), validating that dietary threonine modulates the neural
activity of this homeostatic sleep driver.
We next asked if metabotropic GABA transmission in R2 EB neurons would contribute to SPET.
The RNAi-mediated depletion of GABAB-R2 or GABAB-R3 in R2 EB neurons modestly promoted
sleep in control-fed conditions (Figure 5C). Moreover, it significantly masked SPET on sleep amount
(p=0.0093 for GABAB-R2; p=0.0007 for GABAB-R3 by two-way ANOVA) and on sleep latency
(p=0.0072 for GABAB-R2; p<0.0001 for GABAB-R3 by two-way ANOVA), as compared to heterozy-
gous controls. The GABAB-R3 RNAi phenotypes were consistent with those observed by the pan-
neuronal depletion of GABAB-R3 (Figure 4C). On the other hand, no detectable phenotypes were
observed by the pan-neuronal overexpression of the GABAB-R2 RNAi transgenes, likely due to insuf-
ficient depletion of GABAB-R2 in R2 EB neurons by the pan-neuronal driver (Figure 4—figure sup-
plement 5). Nonetheless, these results indicate that genetic suppression of the metabotropic GABA
transmission in R2 EB neurons phenotypically mimics SPET at the levels of neural activity (i.e., weaker
GABA responses) and sleep behaviors (i.e., higher sleep drive). The sleep phenotypes by the pan-
neuronal, but not R2 EB-specific, depletion of GABAB-R1 (Figure 4C and Figure 5—figure supple-
ment 2) further suggest that this sub-type of metabotropic GABA receptors may be expressed in
non-R2 EB neurons to mediate sleep-regulatory transmission relevant to SPET.
SPET rescues short-term memory in fly mutants with memory deficit
Inhibitory effects of dietary threonine on metabotropic GABA transmission in R2 EB neurons support
that SPET enhances sleep drive via a physiologically relevant neural locus. Nonetheless, the opera-
tional definition of a sleep episode in our behavioral assays (i.e., no movement for longer than 5 min)
could mislead threonine-induced behavioral quiescence into SPET. Therefore, we took two indepen-
dent approaches to validate that SPET is physiologically relevant to sleep. Sleep deprivation impairs
learning in Drosophila (Seugnet et al., 2008). By contrast, genetic or pharmacological induction of
sleep ameliorates memory deficits in plasticity mutants (Dissel et al., 2015). These observations
have convincingly demonstrated the physiological benefits of sleep in memory formation, and we
Ki and Lim. eLife 2019;8:e40593. DOI: https://doi.org/10.7554/eLife.40593 10 of 24
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thus hypothesized that dietary threonine should rescue memory mutants if it would induce physio-
logically relevant sleep. To test this hypothesis, we employed a short-term memory (STM) test that
was based on aversive phototaxic suppression (Seugnet et al., 2009) (Figure 6A), and examined
possible effects of dietary threonine on STM.
Hypomorphic mutants of D1-like dopamine receptor 1 (dumb2) displayed impairment in STM
(Figure 6B), consistent with previous observation (Seugnet et al., 2008). Dietary threonine substan-
tially improved STM in dumb mutants (Figure 6B), and comparably rescued memory deficit in
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Figure 5. Metabotropic GABA transmission in ellipsoid body R2 neurons contributes to SPET. (A) A representative live-brain image of Epac1-camps (a
transgenic FRET sensor for cAMP) expressed in R2 EB neurons by 58H05-Gal4 driver (left). An inverse correlation between intracellular cAMP levels and
FRET intensity was depicted on the right. CFP, cyan fluorescent protein; YFP, yellow fluorescent protein. (B) Transgenic flies (58H05 > Epac1 camps)
were fed on control or threonine-containing food for 4 days in LD cycles at 25˚C. Whole brains were dissected out and transferred to an imaging
chamber. A time series of the fluorescence images was recorded using a multi-photon microscopy. Where indicated, 100 mM GABA was batch-applied
to the imaging medium. FRET analysis was performed using ZEN software. Averaged histograms of the relative changes in FRET intensity (top) and
their averaged median values (bottom) were shown. Data represent mean ± SEM (n = 10–14). *p<0.05 as determined by Student’s t-test. (C) The RNAi-
mediated deletion of metabotropic GABA receptors (GABAB-R2 and GABAB-R3) in R2 EB neurons induced sleep in control-fed condition and masked
SPET. Sleep behaviors in individual male flies were monitored similarly to the data presented in Figure 4C. Two-way ANOVA detected significant
masking of SPET by the overexpression of RNAi transgenes in R2 EB neurons on sleep amount (F[2,161]=4.818, p=0.0093 for GABAB-R2
RNAi#2; F[2,133]
=7.669, p=0.0007 for GABAB-R3
RNAi#1) and sleep latency (F[2,161]=5.088, p=0.0072 for GABAB-R2
RNAi#2; F[2,133]=14.65, p<0.0001 for GABAB-R3
RNAi#1)
as compared to their heterozygous controls. Error bars indicate mean ±95% CI (n = 17–34). n.s., not significant; *p<0.05, **p<0.01, ***p<0.001 as
determined by Tukey’s multiple comparisons.
DOI: https://doi.org/10.7554/eLife.40593.023
The following figure supplements are available for figure 5:
Figure supplement 1. R2 EB neurons are GABA-ceptive.
DOI: https://doi.org/10.7554/eLife.40593.024
Figure supplement 2. Transgenic depletion of metabotropic GABA receptor R1 in R2 EB neurons does not affect SPET.
DOI: https://doi.org/10.7554/eLife.40593.025
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plasticity mutants of rutabaga, a Drosophila homolog of adenylate cyclase (Dissel et al., 2015) (Fig-
ure 6—figure supplement 1). To confirm that memory rescue actually requires threonine-induced
sleep, we pharmacologically deprived sleep in dumb mutants by oral administration of caffeine
(Andretic et al., 2008; Nall et al., 2016; Wu et al., 2009), and tested its effects on the threonine-
dependent rescue of STM in dumb mutants. SPET and caffeine-induced arousal displayed additive
effects on daily sleep amount in control flies (Figure 6C, p=0.5963 by two-way ANOVA) while negli-
gibly affecting their performance index in the memory test (Figure 6B). Consistent with the implica-
tion of dopaminergic activation in caffeine-induced arousal (Andretic et al., 2008; Nall et al., 2016),
baseline sleep in dumb mutants were relatively insensitive to caffeine. Co-administration of caffeine
and threonine, however, suppressed dumb mutant sleep more evidently than caffeine alone
(Figure 6B), and blocked the improvement of their memory deficit by dietary threonine (Figure 6C,
p=0.0435 by two-way ANOVA).
Genetic elevation of endogenous threonine levels facilitates sleep
onset
We next asked if a physiologically relevant increase in threonine levels could act as an endogenous
promoter of sleep. We hypothesized that genetic mutations in threonine-metabolizing enzymes
might elevate the steady-state levels of endogenous threonine. CG5955 is a fly homolog of threo-
nine 3-dehydrogenase that converts threonine and NAD+ into L-2-amino-acetoacetate, NADH, and
H+ (Figure 7A). We identified a transposable P-element insertion in the proximal promoter region of
the CG5955 locus that reduced the relative levels of CG5955 mRNA (Figure 7B and C). Biochemical
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Figure 6. Dietary threonine rescues short-term memory in dumb mutants with memory deficit in a sleep-dependent manner. (A) An experimental
design of the short-term memory (STM) test after three cycles of training on aversive phototaxis suppression. Wild-type (Canton S) or dumb2 mutant
flies were individually loaded on to 5% sucrose food containing either 0 mM (control) or 25 mM threonine (day 0), and then entrained for 3 days in LD
cycles at 25˚C. Where indicated, 0.5 mg/ml of caffeine was added to the behavior food. Locomotor activity in individual male flies was monitored using
the DAM system to analyze sleep behaviors on day 3 prior to the STM test on day 4. (B) The performance index during the test session was calculated
in individual flies and averaged for each condition. Two-way ANOVA detected no significant effects of threonine or caffeine on STM in control flies (F
[1,41]=0.9644, p=0.3318 for threonine; [1,41]=0.1433, p=0.7070 for caffeine). By contrast, two-way ANOVA detected significant interaction between
threonine and caffeine on STM in dumb mutants (F[1,43]=4.329, p=0.0435). Data represent average ± SEM (n = 10–13). (C) Sleep behaviors in individual
male flies were analyzed similarly to the data presented in Figure 1A. Two-way ANOVA detected significant effects of threonine or caffeine on daily
sleep amount in control flies (F[1,62]=18.41, p<0.0001 for threonine; F[1,62]=22.26, p<0.0001 for caffeine), but not their significant interaction (F[1,62]
=0.2836, p=0.5963). Additive effects of threonine and caffeine on daily sleep amount were also observed in dumb mutants (F[1,56]=1.091, p=0.3007 by
two-way ANOVA). Error bars indicate mean ±95% CI (n = 11–19). n.s., not significant; *p<0.05 as determined by Tukey’s multiple comparisons test.
DOI: https://doi.org/10.7554/eLife.40593.026
The following figure supplement is available for figure 6:
Figure supplement 1. Dietary threonine rescues short-term memory in rutabaga mutants with memory deficit.
DOI: https://doi.org/10.7554/eLife.40593.027
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analyses of fly extracts confirmed that CG5955 mutants trans-heterozygous for the hypomorphic
allele over chromosomal deficiency displayed a higher ratio of threonine to total protein levels than
heterozygous controls (Figure 7C). Behavioral analyses revealed that either homozygous or trans-
heterozygous mutation in CG5955 increased daily sleep amounts compared to heterozygous con-
trols (Figure 7D). Moreover, the latency to sleep onset after lights-off was strongly shortened in
CG5955 mutants, indicating a high sleep drive. We further found that pan-neuronal depletion of
CG5955 expression was sufficient to mimic CG5955 mutants in terms of their sleep latency pheno-
type (Figure 7E). Since genetic manipulations of a metabolic enzyme can lead to compensating
changes in relevant metabolic pathways or development, we do not exclude the possibility that
these indirect effects may have contributed to the higher sleep drive observed in CG5955 mutants.
Nonetheless, our genetic, biochemical, and behavioral evidence supports that threonine metabolism
in the brain modulates sleep drive in flies.
Discussion
The molecular and neural machinery of sleep regulation intimately interacts with external (e.g., light,
temperature) and internal sleep cues (e.g., sleep pressure, metabolic state) to adjust the sleep
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Figure 7. Genetic suppression of threonine 3-dehydrogenase elevates endogenous threonine levels and facilitates sleep onset. (A) A threonine
metabolism catalyzed by threonine 3-dehydrogenase (CG5955). (B) A hypomorphic mutant allele of the P element insertion ([GS20382]) in the CG5955
locus. An amplicon used in quantitative PCR was depicted by a gray line. (C) Trans-heterozygous mutations in CG5955 reduced CG5955 mRNA levels
(left, normalized to polyA-binding protein mRNA levels) but elevated endogenous threonine levels (right, normalized to protein levels). Data represent
mean ± SEM (n = 3). *p<0.05, **p<0.01, ***p<0.001 as determined by one-way ANOVA, Tukey’s multiple comparisons test. (D) Loss-of-function
mutations in CG5955 promoted sleep. CG5955 mutants were loaded on to 5% sucrose (day 0) and entrained in LD cycles at 25˚C. Sleep behaviors in
individual female flies were analyzed on day 3 and averaged for each genotype. Error bars indicate mean ±95% CI (n = 26–76). *p<0.05, ***p<0.001 as
determined by one-way ANOVA, Tukey’s multiple comparisons test. (E) Pan-neuronal depletion of CG5955 expression shortened sleep latency. Sleep
behaviors in individual male flies were analyzed as described above due to the X-chromosomal insertion of the pan-neuronal ELAV-Gal4 driver. DICER-2
was co-expressed with each of two independent RNAi transgenes (CG5955RNAi #1 and CG5955RNAi #2) to enhance the RNAi effects. Error bars indicate
mean ±95% CI (n = 20–64). n.s., not significant; *p<0.05, **p<0.01, ***p<0.001 as determined by one-way ANOVA, Dunnett’s multiple comparisons test.
DOI: https://doi.org/10.7554/eLife.40593.028
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architecture in animals. Using a Drosophila genetic model, we have investigated whether dietary
amino acids could affect sleep behaviors and thereby discovered SPET. Previous studies have dem-
onstrated that the wake-promoting circadian pacemaker neurons are crucial for timing sleep onset
after lights-off in LD cycles (Agosto et al., 2008; Chung et al., 2009; Liu et al., 2014a;
Parisky et al., 2008). In addition, WAKE-dependent silencing of clock neurons and its collaborative
function with RDL have been suggested as a key mechanism in the circadian control of sleep onset
(Liu et al., 2014a). However, our evidence indicates that SPET facilitates sleep onset in a manner
independent of circadian clocks. We further elucidate that SPET operates likely via the down-regula-
tion of metabotropic GABA transmission in R2 EB neurons, a neural locus for generating homeo-
static sleep drive (Liu et al., 2016).
Both food availability and nutritional quality substantially affect sleep behaviors in Drosophila.
Sucrose contents in food and their gustatory perception dominate over dietary protein to affect daily
sleep (Catterson et al., 2010; Linford et al., 2012; Linford et al., 2015). Starvation promotes
arousal in a manner dependent on the circadian clock genes Clock and cycle (Keene et al., 2010) as
well as neuropeptide F (NPF), which is a fly ortholog of mammalian neuropeptide Y (Chung et al.,
2017). On the other hand, protein is one of the nutrients that contribute to the postprandial sleep
drive in Drosophila (Murphy et al., 2016) and this observation is possibly relevant to SPET. While
Leucokinin (Lk) and Lk receptor (Lkr) play important roles in dietary protein-induced postprandial
sleep (Murphy et al., 2016) and in starvation-induced arousal (Murakami et al., 2016), we observed
comparable SPET between hypomorphic mutants of Lk or Lkr and their heterozygous controls (Fig-
ure 1—figure supplement 8). Therefore, SPET and its neural basis reveal a sleep-regulatory mecha-
nism distinct from those involved in sleep plasticity relevant to food intake.
What will be the molecular basis of SPET? Given the general implication of GABA in sleep promo-
tion, a simple model will be that a molecular sensor expressed in a subset of GABAergic neurons (i.
e., LN) directly responds to an increase in threonine levels, activates GABA transmission, and thereby
induces sleep. Several lines of our evidence, however, favored the other model that dietary threo-
nine actually down-regulates metabotropic GABA transmission in R2 EB neurons, de-represses the
neural locus for generating homeostatic sleep drive, and thereby enhances sleep drive. The latter
model does not necessarily conflict with sleep-promoting effects of genetic or pharmacological con-
ditions that generally elevate GABA levels or enhance GABAergic transmission since those effects
will be the net outcome of activated GABA transmission via various sub-types of GABA receptors
expressed in either wake- or sleep-promoting neurons and their circuitry.
The structural homology among threonine, GABA, and their metabolic derivatives (e.g., alpha-
ketobutyrate and gamma-hydroxybutyrate) led us to the hypothesis that these relevant chemicals
may act as competitive substrates in enzymatic reactions for their overlapping metabolism (Fig-
ure 4—figure supplement 6). Consequently, dietary threonine may limit the total flux of GABA-glu-
tamate-glutamine cycle possibly through substrate competition, decreases the size of available
GABA pool, and thereby down-scales GABA transmission for SPET. This accounts for why genetic or
pharmacological elevation of GABA levels rather suppresses SPET. Threonine, GABA, and their
derivatives may also act as competitive ligands for metabotropic GABA receptors, explaining weak
GABA responses in R2 EB neurons of threonine-fed flies. Biochemical and neural evidence support-
ive of this hypothesis is quite abundant. It has been previously shown that alpha-ketobutyrate,
GABA, and the ketone body beta-hydroxybutyrate act as competitive substrates in common enzy-
matic reactions (Beyerinck and Brass, 1987; Lund et al., 2011; Suzuki et al., 2009). Moreover,
functional interactions of beta-hydroxybutyrate or gamma-hydroxybutyrate with GABAergic signal-
ing have been well documented (Absalom et al., 2012; Carter et al., 2009; Carter et al., 2005;
Lund et al., 2011; Nasrallah et al., 2010; Snead and Gibson, 2005; Suzuki et al., 2009). Finally,
threonine and GABA derivatives have anti-convulsive effects (Growdon et al., 1991; Hauser et al.,
1992; Lee et al., 1990), which further support their common structural and functional relevance to
GABAergic signaling.
The removal of the amino group is the initial step for amino acid metabolism, and various transa-
minases mediate its transfer between amino acids and alpha-keto acids. On the other hand, a group
of amino acids (i.e., glutamate, glycine, serine, and threonine) has their own deaminases that can
selectively remove the amino group (Bender, 2014). The presence of these specific deaminases is
indicative of active mechanisms that individually fine-tune the baseline levels of these amino acids in
metabolism, and possibly in the context of other physiological processes as well. This idea is further
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supported by the conserved roles of glutamate, glycine, and serine as neurotransmitters or neuro-
modulators important for brain function, including sleep regulation (Kawai et al., 2015;
Tomita et al., 2017; Zimmerman et al., 2017). In fact, serine, glycine, and threonine constitute a
common metabolic pathway (Figure 4—figure supplement 2), and threonine may contribute indi-
rectly to glycine- or serine-dependent activation of sleep-promoting NMDAR (Kawai et al., 2015;
Tomita et al., 2015). Nonetheless, we found that sleep-modulatory effects of dietary glycine were
distinct from SPET and thus, we speculate that threonine may act as an independent neuromodula-
tor, similar to other amino acids with their dedicated deaminases.
While several lines of our data support that threonine is likely to be an endogenous sleep driver
in fed conditions, we have recently demonstrated that starvation induces serine biosynthesis in the
brain and neuronal serine subsequently suppresses sleep via cholinergic signaling (Sonn et al.,
2018). These two pieces of our relevant works establish a compelling model that the metabolic path-
way of serine-glycine-threonine functions as a key sleep-regulatory module in response to metabolic
sleep cues (e.g., food ingredients and dietary stress). We further hypothesize that the adaptive con-
trol of sleep behaviors by select amino acids and their conserved metabolic pathway suggests an
ancestral nature of their sleep regulation. Future studies should address if the serine-glycine-threo-
nine metabolic pathway constitutes the sleep homeostat that can sense and respond to different
types of sleep needs. In addition, it will be interesting to determine if this metabolic regulation of
sleep is conserved among other animals, including humans.
Materials and methods
Key resources table
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Genetic
reagent
(D. melanogaster)
w1118 Bloomington
Drosophila
Stock Center
RRID:BDSC_5905
Genetic
reagent
(D. melanogaster)
Canton S Korea Drosophila
Resource Center
Stock #K211
Genetic
reagent
(D. melanogaster)
CG5955GS20382 Kyoto Drosophila
Genomics and
Genetics Resources
RRID:DGGR_201409
Genetic
reagent
(D. melanogaster)
Df(3L)BSC797 Bloomington
Drosophila
Stock Center
RRID:BDSC_27369 CG5955 deficiency
Genetic
reagent
(D. melanogaster)
Df(3L)BSC839 Bloomington
Drosophila
Stock Center
RRID:BDSC_27917 CG5955 deficiency
Genetic
reagent
(D. melanogaster)
rut2080 Bloomington
Drosophila
Stock Center
RRID:BDSC_9405
Genetic
reagent
(D. melanogaster)
DA1dumb2 Harvard Medical School RRID:
FlyBase_FBst1017920
Dop1R1f02676
Genetic
reagent
(D. melanogaster)
ELAV-Gal4 Bloomington
Drosophila
Stock Center
RRID:BDSC_458
Genetic
reagent
(D. melanogaster)
GAD1-Gal4 Bloomington
Drosophila
Stock Center
RRID:BDSC_51630
Genetic
reagent
(D. melanogaster)
58H05-Gal4 Bloomington
Drosophila
Stock Center
RRID:BDSC_39198
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Genetic
reagent
(D. melanogaster)
Gr5a-Gal4 Bloomington
Drosophila
Stock Center
RRID:BDSC_57591
Genetic
reagent
(D. melanogaster)
Gr33a-Gal4 Bloomington
Drosophila
Stock Center
RRID:BDSC_31425
Genetic
reagent
(D. melanogaster)
Gr66a-Gal4 Bloomington
Drosophila
Stock Center
RRID:BDSC_28801
Genetic
reagent
(D. melanogaster)
Orco-Gal4 Bloomington
Drosophila
Stock Center
RRID:BDSC_26818
Genetic
reagent
(D. melanogaster)
Lkc275 Bloomington
Drosophila
Stock Center
RRID:BDSC_16324
Genetic
reagent
(D. melanogaster)
Df(3L)Exel6123 Bloomington
Drosophila
Stock Center
RRID:BDSC_7602 Lk deficiency
Genetic
reagent
(D. melanogaster)
Lkrc003 Bloomington
Drosophila
Stock Center
RRID:BDSC_16250
Genetic
reagent
(D. melanogaster)
Df(3L)BSC557 Bloomington Drosophila Stock Center RRID:BDSC_25119 Lkr deficiency
Genetic
reagent
(D. melanogaster)
per01 PMID: 9630223 RRID:BDSC_80917
Genetic
reagent
(D. melanogaster)
ClkJrk PMID: 9630223 RRID:BDSC_24515
Genetic
reagent
(D. melanogaster)
PDF-Gal4 PMID: 10619432
Genetic
reagent
(D. melanogaster)
UAS-ClkDN Tanoue et al., 2004 RRID:BDSC_36318
Genetic
reagent
(D. melanogaster)
RdlMDRR Kyoto Drosophila
Genomics and
Genetics Resources
RRID:DGGR_106444
Genetic
reagent
(D. melanogaster)
Rdl1 Kyoto Drosophila
Genomics and
Genetics Resources
RRID:DGGR_106453
Genetic
reagent
(D. melanogaster)
GABA-TPL Bloomington
Drosophila
Stock Center
RRID:BDSC_19461 GABATPL00338,
null mutants
Genetic
reagent
(D. melanogaster)
GABA-TF Harvard Medical
School
RRID:
FlyBase_FBst101711
GABATf01602,
hypomorphic
Genetic
reagent
(D. melanogaster)
GABA-TLL Kyoto Drosophila
Genomics and
Genetics Resources
RRID:DGGR_141269 GABATLL04492,
hypomorphic
Genetic
reagent
(D. melanogaster)
UAS-GABA-T Chen et al., 2015 RRID:FlyBase_FBst0491743
Genetic
reagent
(D. melanogaster)
Df(3L)BSC731 Bloomington
Drosophila
Stock Center
RRID:BDSC_26829 GABA-T deficiency
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Genetic
reagent
(D. melanogaster)
UAS-shibirets Kitamoto, 2001
Genetic
reagent
(D. melanogaster)
30Y-Gal4 Bloomington
Drosophila
Stock Center
RRID:BDSC_30818
Genetic
reagent
(D. melanogaster)
TH-Gal4 Bloomington
Drosophila
Stock Center
RRID:BDSC_8848
Genetic
reagent
(D. melanogaster)
UAS-mLexA-VP16-NFAT Masuyama et al., 2012 RRID:BDSC_66542
Genetic
reagent
(D. melanogaster)
UAS-Epac1-camps Bloomington
Drosophila
Stock Center
RRID:BDSC_25407
Genetic
reagent
(D. melanogaster)
UAS-CG5955RNAi#1 Vienna Drosophila
Resource Center
RRID:
FlyBase_FBst0452036
V15838
Genetic
reagent
(D. melanogaster)
UAS-CG5955RNAi#2 Bloomington
Drosophila
Stock Center
RRID:
BDSC_64566
Genetic
reagent
(D. melanogaster)
UAS-Kir PMID: 11222642
Genetic
reagent
(D. melanogaster)
UAS-GABAB-R1
RNAi#1 Vienna Drosophila
Resource Center
RRID:
FlyBase_FBst0473313
V101440
Genetic
reagent
(D. melanogaster)
UAS-GABAB-R1
RNAi#2 Vienna Drosophila
Resource Center
RRID:
FlyBase_FBst0490977
V330042
Genetic
reagent
(D. melanogaster)
UAS-GABAB-R1
RNAi#3 Bloomington
Drosophila
Stock Center
RRID:BDSC_51817 T51817
Genetic
reagent
(D. melanogaster)
UAS-GABAB-R2
RNAi#1 Vienna Drosophila
Resource Center
RRID:
FlyBase_FBst0452890
V1784
Genetic
reagent
(D. melanogaster)
UAS-GABAB-R2
RNAi#2 Vienna Drosophila
Resource Center
RRID:
FlyBase_FBst0452896
V1785
Genetic
reagent
(D. melanogaster)
UAS-GABAB-R3
RNAi#1 Vienna Drosophila
Resource Center
RRID:
FlyBase_FBst0468888
V50176
Genetic
reagent
(D. melanogaster)
UAS-GABAB-R3
RNAi#2 Vienna Drosophila
Resource Center
RRID:
FlyBase_FBst0477558
V108036
Chemical
compound, drug
EOS Tokyo Chemical
Industry
Cat. No. S0445
Chemical
compound, drug
NipA Sigma Cat. No. 211672
Chemical
compound, drug
THIP Tocris Cat. No. 0807 Also known as
gaboxadol,
2000x stock
Chemical
compound, drug
SKF-97541 Tocris Cat. No. 0379 10000x stock
Chemical
compound, drug
GABA Acros Cat. No. AC103280250 10x stock
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Chemical
compound, drug
Pyruvate Sigma Cat. No. P2256
Chemical
compound, drug
Tetrodotoxin (TTX) Alomone Labs Cat. No. T-550 1000x stock
Chemical
compound, drug
caffeine Alfa Aesar Cat. No. A10431 1000x stock
Antibody Mouse anti-GFP,
monoclonal
UC Davis/NIH
NeuroMab Facility
RRID:AB_10671955 1:1000 dilution
Antibody Rabbit anti-GABA,
polyclonal
Sigma RRID:AB_477652 1:2000 dilution
Antibody Rabbit anti-
TH, polyclonal
Millipore RRID:AB_390204 1:1000 dilution
Antibody Donkey anti-
Mouse AF488
Jackson
Immunoresearch
RRID:AB_2340846 1:600 dilution
Antibody Donkey anti-
Rabbit AF594
Jackson
Immunoresearch
RRID:AB_2340621 1:600 dilution
Sleep analyses
All behavioral tests were performed using individual male flies, unless otherwise indicated. Each fly
was housed in a 65 ! 5 mm glass tube containing 5% sucrose and 2% agar (behavior food). For
amino acid supplements, the indicated amount of each amino acid was dissolved in the behavior
food. For oral administration of GABA-T or GABA transporter inhibitors, 10 mM of EOS (Tokyo
Chemical Industry) or 10 mg/ml of NipA (Sigma) was directly dissolved in the behavior food contain-
ing the indicated amount of threonine. For oral administration of GABA receptor agonists, 10 mg/ml
of THIP (Tocris) or SKF-97541 (Tocris) stock solution was diluted into the behavior food at the indi-
cated final concentration. Flies were fed on amino acid- and/or drug-containing behavior food in LD
cycles at 25˚C for 4.5 days. Locomotor activity was recorded using the DAM system (Trikinetics) and
quantified by the number of infrared beam crosses per minute. Sleep bouts were defined as no
activity for >5 min. Sleep parameters were analyzed using an Excel macro (Pfeiffenberger et al.,
2010).
Measurements of arousal threshold and sleep latency after arousal
The arousal threshold to mechanical stimuli was measured as described previously (Wu et al., 2008)
with minor modifications. Locomotor activities were recorded similarly as in the sleep analyses, while
behavioral test tubes containing individual male flies were scraped with a thin wood stick at zeitge-
ber (ZT) 16 (lights-on at ZT0; lights-off at ZT12) during the fourth LD cycle. Mechanical stimuli used
in our tests include: 1) scraping sound and vibration without direct scraping (a weak stimulus), 2)
gentle scraping (a moderate stimulus), and 3) hard scraping repeated 3–4 times (a strong stimulus).
Flies were defined as aroused if they displayed inactivity for >5 min prior to the stimulus but showed
any stimulus-induced locomotor response within 10 min. The percentage of aroused flies was calcu-
lated per each group in individual experiments and averaged from three independent experiments.
Latency to sleep onset after the arousal was calculated in individual flies and averaged per each
group. To measure the arousal threshold to a light stimulus, LD-entrained flies were exposed to a 1
min light pulse at ZT16 instead of the mechanical stimuli. The percentage of light-aroused flies and
sleep latency after the light-induced arousal were measured similarly as above.
Video analyses of sleep and locomotor activity
Wild-type male flies were placed individually into the video-tracking arena (diameter x height = 16
mm x 2 mm) in a 24-well plate filled with the behavior food (5% sucrose +2% agar±25 mM threonine)
(day 0). Flies were entrained in 12 hr light:12 hr dim red light (red LED) cycles at 25˚C before 24 hr
time-lapse images were obtained at 0.3–1 Hz using HandyAVI software (AZcendant) on day 4. Their
positional changes in X- and Y-axes were calculated from two consecutive frames of the time-lapse
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images per each arena. Any positional difference larger than eight pixels was considered as a move-
ment. A window of the time frames with no positional change for >5 min was defined as a sleep
bout. Additional parameters for sleep or locomotor activity were analyzed using Excel. For the
higher-resolution analysis of locomotor behaviors, male flies were pre-fed on control or amino acid-
containing behavior food for four LD cycles at 25˚C. After brief anesthetization, flies were individually
placed into 6-well plates (diameter x height = 35 mm x 2 mm). After 25 min of habituation, time-
lapse images were obtained at 10 Hz using HandyAVI software (AZcendant). Approximately 3000
frames (corresponding to a 5 min video recording) were analyzed using ImageJ software to quantify
locomotor activity in individual flies as described above.
Aversive phototaxic suppression (APS)
An APS-based short-term memory test was performed as described previously (Dissel et al., 2015;
Seugnet et al., 2009). Briefly, adult male flies were individually housed and fed either control or
threonine-containing behavior food for four LD cycles. A single fly was placed in the dark chamber
of a T-maze without anesthesia. A filter paper (3M) was soaked with 180 mL of 1 mM quinine hydro-
chloride solution (Sigma) and was placed in the light chamber to give aversive condition in concor-
dance with a light stimulus. After 1 min of habituation in the T-maze, a middle bridge between two
chambers was opened and the light source was gradually turned on. Any fly which did not move to
the light chamber at the first trial was excluded from further analysis. If a fly entered the light cham-
ber within 20 secs, it was considered as a pass. The whole procedure was repeated 16 times in four
sessions (four trials/session) at 1 min intervals. A performance index was calculated per each fly by
the percentage of ‘non-pass’ in the last session.
Whole-brain imaging
Transgenic flies were fed on control or amino acid-containing behavior food for four LD cycles at 25˚
C prior to imaging experiments. Whole brains were dissected in phosphate-buffered saline (PBS)
and fixed in PBS containing 3.7% formaldehyde. Fixed brains were washed three times in PBS con-
taining 0.3% Triton X-100 (PBS-T), blocked in PBS-T containing 0.5% normal goat serum, and then
incubated with mouse anti-GFP (NeuroMab) and rabbit anti-GABA (Sigma) antibodies for 2 days at
4˚C. After washing three times in PBS-T, brains were further incubated with anti-mouse Alexa Fluor
488 and anti-rabbit Alexa Fluor 594 antibodies (Jackson ImmunoResearch) for 1 day at 4˚C, washed
three times with PBS-T, and then mounted in VECTASHIELD mounting medium (Vector Laborato-
ries). Confocal images of whole-mount brains were acquired using a Multi-Photon Confocal Micro-
scope (LSM780NLO, Carl Zeiss) and analyzed using ImageJ software.
In vivo Epac1-camps imaging
Transgenic flies fed either control or threonine-containing behavior food were anesthetized in ice. A
whole brain was briefly dissected in hemolymph-like HL3 solution (5 mM HEPES pH 7.2, 70 mM
NaCl, 5 mM KCl, 1.5 mM CaCl2, 20 mM MgCl2, 10 mM NaHCO3, 5 mM Trehalose, 115 mM Sucrose)
and then placed on a 25 mm round coverslip. A magnetic imaging chamber (Chamlide CMB, Live
Cell Instrument) was assembled on the coverslip and filled with 900 ml of HL3 solution. Where indi-
cated, 100 ml of 10x GABA stock solution in HL3 was added to the imaging samples. Live-brain
images were acquired at ~1 Hz using a multi-photon confocal microscope (LSM780NLO, Carl Zeiss)
with a Plan-Apochromat 40x/1.3 oil lens. The power of a 458 nm-laser projection was 3% at a pixel
resolution of 256 ! 256. Each frame constituted two slices by ~5 mm of step sizes. Gallium arsenide
phosphide (GaAsP) detectors were set by two ranges (473–491 nm and 509–535 nm) for ECFP and
EYFP channels, respectively. Pinhole was fully opened (599 mm) to avoid any subtle z-drift during the
image acquirement. The fluorescence intensities of CFP and YFP were quantified using ZEN software
(Carl Zeiss) and any changes in FRET signals were calculated in Excel.
Quantitative PCR
Total RNA was purified from 10 flies per each genotype (five males and five females) using Trizol
Reagent, according to the manufacturer’s instructions (Thermo Fisher Scientific). cDNA was pre-
pared from DNase I-treated RNA samples using the M-MLV Reverse Transcriptase reagent (Prom-
ega) and random hexamers. Diluted cDNA samples were quantitatively analyzed by SYBR Green-
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based Prime Q-Mastermix (GeNet Bio) and gene-specific primers using the LightCycler 480 real-time
PCR system (Roche). To validate the efficiency of transgenic RNA interference, total RNAs from
head or body extracts were analyzed similarly.
Quantification of threonine levels
Quantitative measurement of threonine was performed as described previously (Liu et al., 2014b)
with minor modifications. Briefly, 30 female flies were homogenized in 200 mL of PBS containing
0.05% Triton X-100. Whole-body extracts were clarified twice by centrifugation, and total proteins in
the extracts were quantified using the Pierce BCA Protein Assay Kit according to manufacturer’s
instructions (Thermo Fisher Scientific). After boiling, soluble extracts were further clarified by centri-
fugation and subjected to an enzymatic reaction. Each reaction mixture included 40 mL of
5 ! HEPES reaction buffer (500 mM HEPES pH 8.0, 1 mM NADH, 0.25 mM pyridoxal 5-phosphate,
and 5 mM dithiothreitol), 160 mL of soluble body extracts, and 1 U of alcohol dehydrogenase
(Sigma). In parallel, control reactions with a serial dilution of threonine stock solution (16 mM) were
used to generate a standard curve for quantification. The enzymatic reactions were set up in a 96-
well microplate (Corning) and incubated for 30 min at 4˚C followed by 10 min incubation at 25˚C.
Absorbance at 340 nm was measured for each reaction mixture using an Infinite M200 microplate
reader (Tecan) before 1 mL of bacterially purified L-threonine aldolase (LTA) was added to each reac-
tion mixture. The reaction mixture was further incubated at 37˚C for 5 min and post-LTA absorbance
was measured to calculate decreases in NADH levels.
Protein purification of L-threonine aldolase
The coding sequence of LTA was PCR-amplified from genomic DNA of Pseudomonas aeruginosa (a
gift from R.J. Mitchell) and cloned into a modified pDuet vector (a gift from C. Lee). Bacterial purifi-
cation of His-tagged LTA proteins using Ni-NTA Agarose (Qiagen) was performed as described pre-
viously (Lee et al., 2017). Purified proteins were dialyzed using a dialysis buffer (50 mM NaH2PO4,
pH 8.0, 10 mM pyridoxal 5-phosphate, and 1 mM dithiothreitol), diluted in 50% glycerol, quantified
using Pierce BCA Protein Assay Kit (Thermo Fisher Scientific), and stored at "80˚C prior to use.
Quantitative analyses of free amino acids and energy metabolites
Wild-type male flies were loaded on to standard cornmeal-yeast-agar food containing either 0 mM
(control) or 50 mM threonine, and then entrained in LD cycles at 25˚C for 4 days before harvest.
Extracts were prepared from 100 fly heads per condition and the relative levels of free amino acids
were measured using ion exchange chromatography as described previously (Sonn et al., 2018). For
quantification of energy metabolites, fly heads were homogenized in 400 ml of chloroform/methanol
(2/1, v/v) and clarified by centrifugation. The supernatant was dried by vacuum centrifugation, and
then reconstituted with 50 mL of 50% acetonitrile prior to liquid chromatography-tandem mass spec-
trometry analysis using 1290 HPLC (Agilent), Qtrap 5500 (ABSciex), and a reverse phase column
(Synergi fusion RP 50 ! 2 mm).
Statistics
Appropriate sample sizes were not determined by statistical computation but based on those
reported in previous studies. For all the analyses, ‘n’ refers to the total number of biological repli-
cates which were tested in more than two independent experiments, unless otherwise indicated in
figure legends. For immunofluorescence assay, ‘n’ refers to the total number of brain hemispheres
which were tested in 2–4 independent experiments. For cAMP imaging, ‘n’ refers to the total num-
ber of brains which were tested in 2–3 independent experiments. Individual flies were allocated into
each group of biological replicates by their specific diet or genotype. Raw sleep data were collected
non-blindly to the conditions but analyzed by an automated macro program. For immunofluores-
cence assay, GFP-positive neurons were scored in a way of double-blinded to the conditions. Short-
term memory tests were performed blindly to the conditions. All the statistical analyses were per-
formed using Prism (GraphPad Software, Inc) as described in figure legends. F distributions with
degrees of freedom were indicated by F[DFn, DFd]. All the P values from post hoc tests after one-
way or two-way ANOVA were corrected for multiple comparisons. Violin plots present mean ± 95%
Ki and Lim. eLife 2019;8:e40593. DOI: https://doi.org/10.7554/eLife.40593 20 of 24
Research Communication Genetics and Genomics Neuroscience
confidence intervals and were generated using Python with the help of Seaborn library. Bar graphs
indicate mean ± SEM and were generated using Excel.
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